首页|期刊导航|mLife|Thirteen-year genomic analysis(2010-2022)reveals high-risk ICU Pseudomonas aeruginosa in China

Thirteen-year genomic analysis(2010-2022)reveals high-risk ICU Pseudomonas aeruginosa in ChinaOA

中文摘要

Pseudomonas aeruginosa is a significant opportunistic pathogen,particularly prevalent in intensive care units(ICUs).Through a comprehensive genomic and phenotypic analysis of 518 ICU and healthy isolates collected over a 13-year period(2010-2022),we found that ICU strains,despite reduced sequence type(ST)diversity,are dominated by persistent high-risk clones,notably ST463 and ST1076.Despite possessing a lower overall prophage content,ICU isolates show a broader and more diverse repertoire of anti-phage defense systems.This strengthened defense capacity correlates with ICU strains,demonstrating heightened resistance to phage challenge and contributing to lower historical phage exposure.Concurrently,ICU isolates harbor a significantly higher antimicrobial resistance(AMR)gene burden.Our detailed genomic analysis shows that this increased AMR is primarily driven by plasmid acquisition.Importantly,AMR genes associated with prophage elements are exclusively found in ICU isolates,highlighting their selective retention and functional contribution to resistance in this high-pressure environment.Furthermore,specific virulence genes,including exoU,pilA,and rhsP2,are more prevalent in ICU strains,indicating enhanced pathogenicity.Collectively,these findings underscore a qualitative distinction in ICU P.aeruginosa:their dominance and persistence stem from highly adapted clones,robust anti-phage defenses,rapid plasmidmediated AMR acquisition,and clinically selected prophage-borne AMR.

Jiadai Huang;Kaichao Chen;Miaomiao Xie;Weiyi Shen;Xiaoyang Ju;Yuchen Wu;Jiaping Li;Hongwei Zhou;Yonglu Huang;Yizhou Zhang;Yuanfeng Zhang;Tianmin Li;Letong Xu;Yue Sun;Fang Chen;Sheng Chen;Xin Deng;Rong Zhang;Yanyan Hu

Department of Clinical Laboratory,Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou,China Department of Biomedical Sciences,College of Biomedicine,City University of Hong Kong,Hong Kong,China Shenzhen Research Institute,City University of Hong Kong,Shenzhen,ChinaState Key Lab for Chemical Biology and Drug Discover and the Department of Food Science and Nutrition,Faculty of Science,The Hong Kong Polytechnic University,Hong Kong,ChinaState Key Lab for Chemical Biology and Drug Discover and the Department of Food Science and Nutrition,Faculty of Science,The Hong Kong Polytechnic University,Hong Kong,ChinaDepartment of Clinical Laboratory,Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou,ChinaDepartment of Clinical Laboratory,Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou,ChinaDepartment of Clinical Laboratory,Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou,ChinaDepartment of Clinical Laboratory,Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou,ChinaDepartment of Clinical Laboratory,Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou,ChinaDepartment of Clinical Laboratory,Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou,ChinaDepartment of Biomedical Sciences,College of Biomedicine,City University of Hong Kong,Hong Kong,ChinaDepartment of Biomedical Sciences,College of Biomedicine,City University of Hong Kong,Hong Kong,ChinaDepartment of Biomedical Sciences,College of Biomedicine,City University of Hong Kong,Hong Kong,ChinaDepartment of Biomedical Sciences,College of Biomedicine,City University of Hong Kong,Hong Kong,ChinaDepartment of Biomedical Sciences,College of Biomedicine,City University of Hong Kong,Hong Kong,ChinaDepartment of Biomedical Sciences,College of Biomedicine,City University of Hong Kong,Hong Kong,ChinaState Key Lab for Chemical Biology and Drug Discover and the Department of Food Science and Nutrition,Faculty of Science,The Hong Kong Polytechnic University,Hong Kong,ChinaDepartment of Biomedical Sciences,College of Biomedicine,City University of Hong Kong,Hong Kong,China Shenzhen Research Institute,City University of Hong Kong,Shenzhen,ChinaDepartment of Clinical Laboratory,Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou,ChinaDepartment of Clinical Laboratory,Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou,China

医药卫生

antibiotic resistanceICUphagePseudomonas aeruginosavirulence

《mLife》 2026 (4)

P.459-472,14

supported by the grants from the Natural Science Foundation of Zhejiang Province(No.LMS25H200003 to Y.H.)the National Key Research and Development Program of China(No.2022YFD1800400 to R.Z.)the National Natural Science Foundation of China(Nos.32172358,32570202 to X.D.)the Sichuan Science and Technology Program(No.2024ZYD0134 to X.D.)the General Research Funds of Hong Kong,China(Nos.11101722,11102223,and 11103221 to X.D.)the Health and Medical Research Fund(No.20190942 to X.D.)the Hong Kong Research Grants Council Collaborative Research Fund(No.CRF C7033-20G)the Theme-based Research Scheme(No.T11-104/22-R to X.D.)the Guangdong Major Project of Basic and Applied Basic Research(No.2020B0301030005 to X.D.).

10.1002/mlf2.70097

评论